Schreiner MediPharm, a Germany-based global provider of pharmaceutical labels, has opened its first US production facility, in Blauvelt, New York. The 15,240 sq m facility will be fully validated and ISO-certified and feature a variety of advanced screen and flexo printing technologies, according to Schreiner. Specialty peel-off labels, expanded content labels, combination hanger labels, functional syringe labels, brand protection and RFID solutions will all be produced on site. Acceleron Pharma has commenced plans to increase its headcount by 40 per cent and double the size of its administrative, laboratory and manufacturing facilities in Cambridge, USA. It is thought the expansion will create a second manufacturing facility for growth and differentiation factors-related proteins, with the company expecting to begin Phase II studies with ACE-011 later this year. Malaysia-based YSP Southeast Asia Holdings has allocated $12m to build a manufacturing facility in Vietnam producing its pharmaceutical products. The site is due to be brought online before the end of next year and YSP expect it to generate 10 per cent of its total revenue by 2010. Speaking to The Edge Financial Daily, Dr Frank Lee, YSP's president and group, said: "We see huge potential in that country, especially with its relatively young population. We will grow with the country and our presence there will be long term." India-based Dishman Pharmaceuticals and Chemicals is planning to build a facility in Shanghai, China, in what will be the company's first oversees greenfield plant. The active pharmaceutical ingredient (API) manufacturer is investing $10m in the site, which it believes will produce 3000 metric tonnes (mt) of quaternary salts and 500mt of medicine intermediates. By 2011 the company is expecting the 40,000 sq m facility to bring in revenues of $20-25m. Shanghai was chosen as a location due to its proximity to Dishman's raw material suppliers. Clean Modules has launched its next generation of modular cleanrooms, which it claims are bigger, stronger and more stable than before. The use of hot rolled steel frames instead of timber is said to make the modular building feel more like a traditionally constructed structure. This use of steel also enables the creation of wider and longer cleanrooms, capable of housing larger rooms. Modules are constructed off-site, with "plug and play" electrics and air systems reducing the installation time. In addition the next-generation models offer superior insulation and fire ratings. Clean Modules markets the structures as a fast and convenient method of adding additional cleanroom space to a facility. A surge in the numbers of Chinese pharmaceutical manufacturers operating in South Africa is on the cards, after the nation tried to woo investors to the Coega industrial zone. Representatives of the Coega Development Corporation have been speaking to the Chinese companies but are not revealing names.
in-PharmaTechnologist.com's periodic round-up of developments in the pharmaceutical manufacturing space includes new facilities, South Africa luring Chinese investors and an advance in modular cleanrooms.